Nav: Home

Sharp rise in breast cancer gene testing after Angelina Jolie's New York Times editorial

December 14, 2016

There was a sharp increase in breast cancer gene testing among US women immediately after Angelina Jolie's New York Times editorial, but no change in overall mastectomy rates, finds a study in the Christmas issue of The BMJ.

The results suggest that celebrity announcements can influence use of healthcare services, but they may not effectively target the groups at greatest risk for the underlying condition, say the researchers.

Celebrity endorsements for health related matters such as preventive screening, fad diets, and supplements are ubiquitous. But evidence on whether celebrity endorsements actually affect health related behaviours remains limited.

In 2013, actress Angelina Jolie announced in the New York Times that she had undergone a double mastectomy (where both breasts are surgically removed) followed by breast reconstruction surgery after genetic testing revealed she had a greatly increased chance of developing breast cancer in later life.

She urged women to consider BRCA gene testing (BRCA1 and BRCA2 are two genes that raise a woman's risk of breast and ovarian cancer if they become altered).

The editorial is one of the most viewed health related articles in the social media age, yet analyses of the editorial's effects on rates of BRCA testing and mastectomy have been limited.

So, using data from over 9 million commercially insured US women aged 18-64 years, Sunita Desai, the Marshall J. Seidman Fellow, at Harvard Medical School, and Anupam Jena, Associate Professor, analysed rates of BRCA testing and mastectomy before and after Jolie's editorial.

Daily BRCA test rates increased immediately and sharply after publication of the editorial. Rates rose from 0.71 tests per 100,000 women in the 15 business days before to 1.13 tests in the 15 business days after 14 May 2013.

In comparison, daily BRCA test rates were relatively similar in the same period in 2012 (0.58 per 100,000 women in the 15 business days before 14 May versus 0.55 tests per 100,000 in the 15 business days after). This corresponds to an absolute daily increase of 0.45 tests per 100,000 women or a 64% relative increase.

However, the researchers saw no overall increase in mastectomy rates, with an average of seven mastectomies a month per 100,000 women during January to April as well as during May to December 2013.

Moreover, among women who had BRCA tests, 60 day monthly mastectomy rates decreased from on average 10% during January to April 2013 to 7% during May to December 2013, further suggesting that additional BRCA testing as a result of the editorial did not identify new BRCA mutations requiring preventive mastectomy.

This also suggests that celebrity announcements can reach a broad audience but may not effectively target the population that would benefit most from the test, in this case women with a family history of breast, ovarian, fallopian tube, or peritoneal cancer, they write.

They point out that this is an observational study, so no firm conclusions can be drawn about cause and effect. However, they say their findings illustrate that well delivered announcements by high profile figures "can raise awareness and use of preventive care by a large and broad audience, although their ability to target subpopulations of interest may be limited."
Research: Do celebrity endorsements matter? Observational study of BRCA gene testing and mastectomy rates after Angelina Jolie's New York Times editorial

About BMJ

BMJ is a healthcare knowledge provider that aims to advance healthcare worldwide by sharing knowledge and expertise to improve experiences, outcomes and value. For a full list of BMJ products and services, please visit

About The BMJ Christmas editions

The BMJ publishes special issues of the BMJ over Christmas and New Year. All submissions follow the standard requirements for The BMJ's articles, and go through the usual peer-review processes. Each paper uses proper research methods and stands up scientifically.


Related Mastectomy Articles:

National clinical trial provides mastectomy alternative for recurrent breast cancer
Mastectomy has historically been the standard treatment for breast cancer patients experiencing recurrence after an initial lumpectomy and whole-breast radiation.
Breast cancer recurrence after lumpectomy & RT is treatable with localized RT without mastectomy
Approximately 10% of breast cancer patients treated with lumpectomy (breast-conserving surgery [BCS]) and whole-breast radiation (WBI) will have a subsequent in-breast local recurrence of cancer (IBTR) when followed long term.
Analysis by surgical trainees examines recommendations for mastectomy across the UK
A woman's decision to undergo mastectomy for breast cancer relies on communication with her surgeon and, in addition, often draws on recommendations from a 'multidisciplinary team' (MDT) of doctors from different specialties such as oncology and radiology.
Less-invasive mastectomy safe for more breast cancer patients, Mayo Clinic study finds
A less-invasive mastectomy that leaves the surface of the breast intact has become a safe option for more patients, including those whose breast cancer has spread to nearby lymph nodes or who have risk factors for surgical complications, a Mayo Clinic study shows.
Future breast imaging and biopsy are not eliminated after mastectomy
A new study led by researchers at the Icahn School of Medicine at Mount Sinai has determined that having a mastectomy does not completely eliminate the need for further breast imaging studies.
Breast cancer detected in transmen undergoing mastectomy
The number of transmen seeking gender-confirming surgery has risen in the past decade.
Web-based decision aid may help with breast reconstruction decisions following mastectomy
A new Psycho-Oncology study indicates that a free web-based decision aid that helps women with breast cancer make decisions regarding reconstruction surgery after mastectomy is likely cost-effective.
Double mastectomy to prevent cancer reduces risk of dying in BRCA1 mutation carriers
Healthy women who carry a breast cancer-causing mutation in the BRCA1 gene, not only reduce their risk of developing the disease but also their chances of dying from it if they have both breasts removed, according to new research presented at the 11th European Breast Cancer Conference.
Breast cancer patients often mispredict well-being after mastectomy
Women with breast cancer who underwent a mastectomy without breast reconstruction generally underestimated their future quality of life, while those who had immediate reconstruction generally overestimated it.
Study finds double mastectomy tied to more missed work
As more breast cancer patients are choosing to remove both breasts, researchers examine the impact this aggressive surgery has on their employment.
More Mastectomy News and Mastectomy Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at